Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Health Policy and Planning
|
August 12, 2025
The impacts of removing pharmaceutical co-payments for chronic conditions at primary care level: a pilot study in rural China
Weijia Lu, Timothy Powell-Jackson, Anne Mills, et al.
Analytical Biochemistry
|
September 13, 2016
Colorimetric aptasensor for progesterone detection based on surfactant-induced aggregation of gold nanoparticles
Gaoshang Du, Lumei Wang, Dongwei Zhang, et al.
Cancer Letters
|
May 25, 2026
Pharmacological Induction of Mitochondria-Lysosome Hyper-Tethering Elicits Synthetic Lethality in Glioblastoma
Dongyuan Su, Yanping Huang, Biao Hong, et al.
Cancer Letters
|
April 3, 2025
ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathway
Chunchao Cheng, Longtao Cui, Xiaoteng Cui, et al.
Neuro-Oncology
|
December 31, 2025
VITA-GBM: EPIC-0502-Driven HIF1α Degradation Overcomes Bevacizumab Resistance and Synergizes with TMZ in Glioblastoma
Yaqing Ding, Qi Zhan, Longtao Cui, et al.
Neuro-Oncology
|
August 31, 2023
EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma
Biao Hong, Eryan Yang, Dongyuan Su, et al.
Neuro-Oncology
|
April 22, 2026
NEU1 Sustains Mitochondria-Lysosome Contacts to Trigger Lysosomal Cu²⁺/Cathepsin Escape and Mitochondrial lysis in Glioblastoma (NeuLysis)
Yanping Huang, Dongyuan Su, Xiaoteng Cui, et al.
Neuro-Oncology
|
October 27, 2025
PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization
Biao Hong, Dongyuan Su, Xiaoteng Cui, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Health Policy and Planning
|
August 12, 2025
The impacts of removing pharmaceutical co-payments for chronic conditions at primary care level: a pilot study in rural China
Weijia Lu, Timothy Powell-Jackson, Anne Mills, et al.
Analytical Biochemistry
|
September 13, 2016
Colorimetric aptasensor for progesterone detection based on surfactant-induced aggregation of gold nanoparticles
Gaoshang Du, Lumei Wang, Dongwei Zhang, et al.
Cancer Letters
|
May 25, 2026
Pharmacological Induction of Mitochondria-Lysosome Hyper-Tethering Elicits Synthetic Lethality in Glioblastoma
Dongyuan Su, Yanping Huang, Biao Hong, et al.
Cancer Letters
|
April 3, 2025
ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathway
Chunchao Cheng, Longtao Cui, Xiaoteng Cui, et al.
Neuro-Oncology
|
December 31, 2025
VITA-GBM: EPIC-0502-Driven HIF1α Degradation Overcomes Bevacizumab Resistance and Synergizes with TMZ in Glioblastoma
Yaqing Ding, Qi Zhan, Longtao Cui, et al.
Neuro-Oncology
|
August 31, 2023
EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma
Biao Hong, Eryan Yang, Dongyuan Su, et al.
Neuro-Oncology
|
April 22, 2026
NEU1 Sustains Mitochondria-Lysosome Contacts to Trigger Lysosomal Cu²⁺/Cathepsin Escape and Mitochondrial lysis in Glioblastoma (NeuLysis)
Yanping Huang, Dongyuan Su, Xiaoteng Cui, et al.
Neuro-Oncology
|
October 27, 2025
PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization
Biao Hong, Dongyuan Su, Xiaoteng Cui, et al.
Page
of 2